| Name | Title | Contact Details |
|---|
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
Financial Medical Systems, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Financial Medical Systems, Inc. is based in Hauppauge, NY. You can find more information on Financial Medical Systems, Inc. at www.finmedsys.com
PreclinPharma is a Englewood, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sunderstorm is a premier California-based lifestyle cannabis manufacturer focused on quality of products, quality of life, and quality of community.
Med 90 Inc is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.